Personalized medicine is the idea and practice of tailoring treatment, diagnosis, or preventive interventions to each patient’s genetic, biomarker, behavioral, and lifestyle characteristics. For example, artificial intelligence (AI) algorithms analyze images, genomes, and clinical data to help select the optimal therapy.
Digital Therapeutics (DTx) is software designed to treat or alleviate diseases, which has undergone clinical trials, has proven effectiveness, and can be prescribed or recommended by a doctor.
For example, apps that help control diabetes, change behavior, or improve mental health are becoming part of treatment alongside traditional methods.
Personalized medicine and digital therapy are not just buzzwords. They are a real transformation that offers a chance to change how we treat, monitor and maintain health. The patient no longer just gets the “average standard”, they get the treatment that is right for them.
Technology allows us to not wait until the disease becomes serious — it allows us to act earlier, more precisely, more effectively. And in this transformation, every direction — genomics, digital platforms, artificial intelligence — becomes part of one big solution: the health of the future today.
The Institute of Nanotechnology and Organic Products “Avelife” improves the methodology and creates modern tools and products to increase crop yields, restore soils and water bodies.
On June 20, 2025, the head of the Institute of Nanotechnologies and Organic Products “AVELIFE”, Timur Levda, attended a fundraising consultation meeting held at the “France” Hotel in Vinnytsia.
In a world where every third banner screams “eco!”, the consumer no longer believes words. He wants to see. Feel. Be immersed. And this is where immersive marketing begins.
